Inpatient and Outpatient Orderable

Hepatitis C Virus (HCV) NS5A Drug Resistance Assay (LabCorp)

Synonyms

HEPATITIS C VIRUS NS5A DRUG RESISTANCE
HEPCNS5A
LAB11829

Cerner Name

Clinical Info

Assessment of drug susceptibility by nucleic acid sequencing of a patient's hepatitis C virus (HCV) to the NS5A inhibitors. Assay should be used for patients with documented HCV genotype 1.

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

Blood

Specimen Volume

2 mL Plasma ( 1 mL min)

Container

Lavender Top Tube

Collection Instructions

Container/Tube: PPT™ tubes or Lavender (EDTA) tube
Specimen: 2 mL Plasma ( 1 mL min)
Transport Temperature: Frozen plasma

Note: Centrifuge specimen within six hours of collection, remove plasma, transfer specimen to polypropylene screw-capped tubes, and freeze. Specimens drawn into PPT™ tubes need to be centrifuged within six hours and frozen.

Limitations This procedure may not be successful when the HCV viral load is <500 IU/mL. This assay requires an HCV genotype of either 1a or 1b

Transport Instructions

Frozen plasma

Specimen Stability

Methodology

Polymerase chain reaction (PCR) amplification and DNA next generation sequencing

Days Performed

TEST DELAY Current TAT 19-23 Days
TAT: 11-15 Days

Performing Laboratory

LabCorp-Monogram Bioscience

CPT

87900
87902

PDM

1659077

Only Orderable at Locations:

Orderable Everywhere

Results

Component Name	Base Name	Common Name	External Name
HCV NS5A RESISTANCE ASSAY PDF	HCVNS5A	HCV NS5A RESISTANCE ASSAY PDF	HCV NS5A Resistance Assay PDF
HCV NS5A DRUG RESISTANCE	HCVNS5A	HCV NS5A DRUG RESISTANCE	HCV NS5A Drug Resistance Assay
HCV NS5A RESIST ASSAY INTERP	HCVNS5A	HCV NS5A RESIST ASSAY INTERP	HCV NS5A Resist Assay Interp

Result Interpretation

See Report

Forms

LAB11829

Search: .supercomplete-item { width: 600px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; } $(document).ready(function() { $("#search_input").supercomplete(); });